Biodesix, Inc. (BDSX)
NASDAQ: BDSX · Real-Time Price · USD
0.3835
-0.0275 (-6.69%)
At close: Aug 13, 2025, 4:00 PM
0.3836
+0.0001 (0.03%)
Pre-market: Aug 14, 2025, 4:33 AM EDT
Paramount Global Market Cap
Biodesix has a market cap or net worth of $56.23 million as of August 13, 2025. Its market cap has decreased by -77.34% in one year.
Market Cap
56.23M
Enterprise Value
108.98M
1-Year Change
-77.34%
Ranking
Category
Stock Price
$0.38
Market Cap Chart
Since October 28, 2020, Biodesix's market cap has decreased from $336.31M to $56.23M, a decrease of -83.28%. That is a compound annual growth rate of -31.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 56.23M | -74.73% |
| Dec 31, 2024 | 222.56M | 33.69% |
| Dec 29, 2023 | 166.48M | -5.38% |
| Dec 30, 2022 | 175.94M | 23.06% |
| Dec 31, 2021 | 142.97M | -73.28% |
| Dec 31, 2020 | 535.07M | 59.10% |
| Oct 28, 2020 | 336.31M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 574.04B |
| Johnson & Johnson | 416.11B |
| AbbVie | 350.91B |
| UnitedHealth Group | 236.90B |
| AstraZeneca | 232.33B |
| Novartis AG | 230.64B |
| Abbott Laboratories | 228.03B |
| Novo Nordisk | 223.00B |